Quantgene

Quantgene is a California-based bioinformatics company that utilizes machine learning to develop its products and solutions, which are geared towardstoward disease detection. It was founded in 2015 in a laboratory on the campus of the University of California, BerkelyBerkeley. The stated mission of the company is to develop solutions for diseases that provide early detection, better prevention, and more effective cures.Incures. In addition to having an office in Santa Monica, the company also has an office in Berlin, Germany.

Quantgene utilizes clinical genomics and medical intelligence systems to develop its products and solutions. The company's main focus is on creating solutions that detect diseases so that they can be treated quickly and effectively.

The company's platform is called The Griffin Deep Genomics Platform and it is powered by deep genomic sequencing and artificial intelligence. The company is creating a data set composed of more than 10,000 patient blood samples so that it can research early cancer detection patterns.

Quantgene is a California-based bioinformatics company that utilizes machine learning to develop its products and solutions, which are geared towards disease detection. It was founded in 2015 in a laboratory on the campus of the University of California, Berkely. The stated mission of the company is to develop solutions for diseases that provide early detection, better prevention, and more effective cures.In addition to having an office in Santa Monica, the company also has an office in Berlin, Germany.

Quantgene Introduction

Quantgene utilizes clinical genomics and medical intelligence systems to develop its products and solutions. The company's main focus is creating solutions that detect diseases so that they can be treated quickly and effectively.

The company's platform is called The Griffin Deep Genomics Platform and it is powered by deep genomic sequencing and artificial intelligence. The company is creating a data set composed of more than 10,000 patient blood samples so that it can research early cancer detection patterns.

Quantgene has developed an at-home testing service called Serenity. The purpose of this service is for people to submit samples so that they can be regularly tested for diseases such as diabetes, heart disease, and cancer. The goal of the yearly or bi-yearly testing is to detect diseases early so they can be treated more successfully than if they were caught after festering for a few years.

Quantgene also developed testing solutions for COVID-19. Included in its offerings are RT-PCR testing kits and a portal that can be accessed by both employers and employees to receive information regarding the test results.